Acadia Healthcare Company, Inc. – Consensus ‘buy’ rating and 20.1% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Acadia Healthcare Company, Inc. which can be found using ticker (ACHC) have now 11 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 105 and 68 calculating the average target price we see $90.09. Given that the stocks previous close was at $75.02 this indicates there is a potential upside of 20.1%. The 50 day moving average now sits at $73.22 and the 200 day MA is $74.65. The total market capitalization for the company now stands at 6.90B. The stock price for the company is currently 74.88 USD

The potential market cap would be $8,288,260,786 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 25.38, revenue per share of 30.77 and a 5.9% return on assets.

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services across the United States. The Company is focused on acquiring and developing behavioral healthcare facilities. The Company is engaged in developing and operating inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States. Its facilities that offer acute care services provide evaluation and crisis stabilization of patients with severe psychiatric diagnoses through a medical delivery model that incorporates structured and intensive medical and behavioral therapies with 24-hour monitoring by a psychiatrist, psychiatric trained nurses, therapists and other direct care staff. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search